NDC product
Desmopressin Acetate
NDC 24208-342 · Bauch & Lomb Incorporated
Key facts
| Product NDC | 24208-342 |
|---|---|
| Proprietary name | Desmopressin Acetate |
| Nonproprietary name | Desmopressin Acetate |
| Substances | DESMOPRESSIN ACETATE |
| Dosage form | SOLUTION |
| Route | NASAL |
| Labeler | Bauch & Lomb Incorporated |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA074830 |
| Pharmacologic classes | Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS] |
| Marketing start | Jan 25, 1999 |
| Marketing end | Feb 28, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory